Skip to content


  • Retraction Note
  • Open Access

Retraction Note: metastatic collecting duct carcinoma of the kidney treated with Sunitinib

  • 1Email author,
  • 1,
  • 2,
  • 2,
  • 1 and
  • 1
World Journal of Surgical Oncology20119:136

  • Received: 21 October 2011
  • Accepted: 24 October 2011
  • Published:

The original article was published in World Journal of Surgical Oncology 2011 9:73


The authors have retracted this article [1] as it contains large portions of text and figures that have been duplicated from another article previously published in the International Journal of Clinical Oncology[2]. Lead author Dr Tazi accepts full responsibly for the duplication and would like to apologise to the co-authors, Editors and readers as well as the authors of the original article.


Authors’ Affiliations

Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco
Department of Urology, CHU Hassan II, Fez, Morocco


  1. Tazi EM, Essadi M, Tazi MF, Ahellal Y, M'rabti H, Errihani H: Metastatic collecting duct carcinoma of the kidney treated with Sunitinib. World Journal of Surgical Oncology. 2011, 9: 73-10.1186/1477-7819-9-73.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Miyake H, Haraguchi T, Takenaka A, Fujisawa M: Metastatic collecting duct carcinoma of the kidney responded to sunitinib. International Journal of Clinical Oncology. 2011, 16: 153-155. 10.1007/s10147-010-0116-z.View ArticlePubMedGoogle Scholar


© Tazi et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.